Fact-checked by Grok 2 weeks ago

Small GTPase

Small GTPases, also known as the of small GTP-binding proteins, are a diverse group of monomeric enzymes, typically 20-25 kDa in size, that function as binary molecular switches in eukaryotic cells by cycling between an active GTP-bound state and an inactive GDP-bound state. This conformational toggling enables them to regulate a broad spectrum of essential cellular processes, including , , cytoskeletal reorganization, vesicle trafficking, , migration, adhesion, and nuclear transport. With over 150 members identified in humans, small GTPases are ubiquitously expressed and play pivotal roles in coordinating cellular architecture and responses to environmental cues. Structurally, small GTPases feature a highly conserved G domain comprising approximately 170-200 , which adopts a Rossmann fold and includes five characteristic motifs (G1 through G5) critical for GTP/GDP binding, , and interactions with regulatory proteins and effectors. Many members also possess a C-terminal that facilitates post-translational lipid modifications, such as or myristoylation, enabling their association with specific intracellular membranes where they exert localized control. These structural elements ensure precise spatiotemporal regulation, with the GTP-bound form exposing switch I and II regions to engage downstream effectors, while the GDP-bound form conceals them. Small GTPases are classified into five major superfamilies based on and function: the family (36 members across subfamilies like , Rap, Ral, Rheb, Rad, Rit, and DIRAS), which primarily governs , survival, and ; the Rho family (22 members, including RhoA, Rac, and Cdc42 subfamilies), which controls actin-myosin dynamics, cell shape, motility, and ; the family (over 60 members), responsible for intracellular vesicle , , and in trafficking pathways; the Arf family (6 members, including Arf and subfamilies), involved in coat protein recruitment for vesicle formation and maintenance; and the Ran family (1 member), which directs nuclear-cytoplasmic transport, mitotic spindle assembly, and reformation. Extensive crosstalk among these families integrates diverse signals to orchestrate complex cellular behaviors. Their activity is tightly modulated by three classes of regulatory proteins that control the cycle: guanine exchange factors (GEFs), which catalyze the release of GDP and promote GTP loading to activate the ; GTPase-activating proteins (GAPs), which enhance the intrinsic GTP hydrolytic activity to return the protein to its inactive state; and guanine dissociation inhibitors (GDIs), which sequester GDP-bound forms in the , preventing localization and spontaneous activation (primarily for Rho and families). This regulatory triad ensures rapid, reversible switching with high fidelity, often amplified through effector cascades that propagate signals. Dysregulation of small GTPases, particularly through point mutations that lock them in the active state (e.g., impairing GTP hydrolysis in Ras proteins), is implicated in numerous pathologies, including approximately 30% of human cancers where Ras mutations drive uncontrolled proliferation, as well as neurological disorders, vascular diseases, and developmental abnormalities. Their central roles have positioned small GTPases as challenging therapeutic targets. Direct inhibitors, particularly for mutations (e.g., G12C), have been approved by the FDA since 2021 for certain cancers like non-small cell , with ongoing efforts to develop broader inhibitors for GEFs, GAPs, or other GTPases to restore cellular . As of 2025, additional approvals such as glecirasib in and combinations like with for are expanding their clinical use.

Overview

Definition and Characteristics

Small GTPases are monomeric GTP-binding proteins classified under the EC 3.6.5.2, functioning as hydrolases that reversibly bind (GTP) and catalyze its to (GDP). These proteins are a type of G-protein found in the and are homologous to the alpha subunits of heterotrimeric G-proteins. Key characteristics of small GTPases include their compact size, typically ranging from 20 to 25 kDa, and their primary localization in the , from where they can associate with cellular membranes upon activation.00655-1) They operate as binary molecular switches in cellular signaling, adopting an active conformation when bound to GTP and an inactive state when bound to GDP; this conformational change is regulated by the GTP/GDP cycle.00655-1) The , to which small GTPases belong, encompasses over 150 members encoded in the and exhibits evolutionary conservation across eukaryotic organisms, underscoring their fundamental role in cellular regulation.

Discovery and Nomenclature

The initial discovery of small GTPases occurred in the early 1980s through studies of retroviral oncogenes. The Harvey rat virus (Ha-MSV) and Kirsten rat virus (Ki-MSV), isolated from rats in the 1960s, were found to encode transforming genes v-H-ras and v-K-ras, respectively, responsible for induction. The nucleotide sequence of the v-H-ras transforming gene in the Ha-MSV genome was determined in 1982, revealing a 21-kDa protein product (p21) with potential GTP-binding motifs. Shortly thereafter, activated human homologs were identified in tumor cells: H-RAS from a cell line via DNA assays, showing transforming activity due to a single ; K-RAS from a , also activated by ; and N-RAS from a cell line. These findings established Ras genes as proto-oncogenes frequently mutated in cancers, marking the beginning of their recognition as key signaling molecules. Milestone events in the mid-1980s expanded the scope beyond mammalian Ras, with cloning of yeast homologs highlighting conserved roles in cellular processes. In 1984, two genes, and RAS2, were cloned and sequenced, encoding proteins with ~80% identity to Ras and essential for viability and adenylate cyclase regulation.90340-4) Between 1984 and 1987, additional homologs were identified, such as RHO1 (1987), involved in integrity, and CDC42 (recognized as Ras-related around 1987, with full cloning in 1990), critical for and division. The nature of these proteins was confirmed in the 1980s through biochemical assays demonstrating GTP binding and low intrinsic hydrolysis rates, drawing analogy to the bacterial EF-Tu based on shared G-domain motifs like GXXXXGK[S/T]. This structural and functional similarity was explicitly mapped in 1985, underscoring their role as molecular switches. Nomenclature evolved alongside these discoveries, shifting from "ras oncogenes" to a broader superfamily framework. The term "small GTPase" (or "small G protein") emerged in the late to distinguish these ~20-30 kDa monomeric GTPases from larger heterotrimeric s, emphasizing their GTP/GDP cycling. By the early 1990s, the was formalized to encompass diverse members sharing ~30-50% sequence identity in the core G domain, including , Rho, , and Arf families. Current classification relies on sequence homology, functional specificity, and conserved domains cataloged in resources like (e.g., PF00071 for the Ras family G domain) and , enabling systematic grouping based on effector interactions and cellular roles. Key structural insights driving this evolution came from researchers like Alfred Wittringhofer, who co-determined the first Ras-GDP in 1989, revealing EF-Tu-like folds, and Frank McCormick, whose work in the -1990s dissected Ras GTPase regulation and signaling.90673-6)

Molecular Structure

Core G Domain

The core G domain represents the highly conserved catalytic module of small GTPases, spanning approximately 170 amino acid residues and serving as the primary site for guanine nucleotide binding and GTP hydrolysis. This domain adopts a canonical fold consisting of a central six-stranded β-sheet flanked by five α-helices, which creates a nucleotide-binding pocket at the interface between the β-sheet and one α-helix. The overall architecture positions the bound nucleotide in a manner that facilitates both high-affinity recognition and enzymatic activity, with the β-sheet providing structural rigidity and the helices contributing to specificity. This structural framework was first revealed by the of the Ha-Ras p21 G domain bound to the GTP analogue GppNHp, determined at 2.0 Å in 1989. Subsequent structures across diverse small GTPase families, including Rho, , and Arf members, demonstrate remarkable conservation of this fold, with root-mean-square deviations (RMSD) below 2 Å upon superposition of core elements, underscoring its evolutionary preservation despite sequence divergence in peripheral regions. Within the nucleotide-binding pocket, the base is nestled into a hydrophobic cleft formed by residues from the G4 and adjacent helices, while the backbone engages electrostatic interactions primarily through basic and polar groups in the G1 and G3 motifs, enabling sub-micromolar affinity for GTP over other . Central to the G domain's function are five motifs (G1–G5) that directly mediate interactions and coordination of the catalytic Mg²⁺ ion. The G1 motif, featuring the P-loop consensus sequence GXXXXGK[S/T], forms a flexible β-strand-loop that binds the α-, β-, and γ-phosphates of GTP via bonds from the and residues. The G2 motif, consisting of a conserved residue in the switch I region, coordinates the Mg²⁺ ion through its hydroxyl side chain, stabilizing the groups and facilitating phosphoryl transfer during . The G3 motif (DXXGQ) lies within the switch II region and interacts with the γ-phosphate via its residue (and associated water), positioning it for nucleophilic attack. The G4 motif (NKXD) provides guanine base specificity through bonds from the and aspartate to the base's exocyclic amino and carbonyl groups, respectively. Finally, the G5 motif (EXSAK or SAK) enhances discrimination by forming additional contacts that exclude ATP, ensuring selective GTP binding.

Effector and Regulatory Regions

Small GTPases possess variable structural elements beyond the conserved G domain that provide functional specificity, including the Switch I and Switch II regions, which undergo nucleotide-dependent conformational changes to facilitate interactions with regulatory proteins. The Switch I region, spanning residues 30–40 in the prototypical protein, adopts a flexible β-strand conformation in the GDP-bound inactive state but transitions to an α-helical structure upon GTP binding, exposing an effector interface that includes key residues like Thr35 for coordination with the γ-phosphate. Similarly, the Switch II region (residues 60–76) shifts from a disordered in the GDP form to a more rigid β-sheet and helical motif in the GTP-bound active state, positioning residues such as Gln61 at the protein surface to influence specificity in downstream interactions. These dynamic switches, conserved across the superfamily, enable the to act as binary molecular switches while distinguishing family-specific signaling. The hypervariable C-terminal region, typically comprising 20–30 residues, exhibits significant sequence diversity among small GTPases and is crucial for subcellular localization through membrane anchoring. In many members, such as , this region features a polybasic cluster of and residues adjacent to a CAAX (C: ; A: aliphatic; X: variable), which promotes electrostatic interactions with negatively charged membranes.80607-8.pdf) The CAAX serves as a signal for post-translational , where the is covalently modified with a 15-carbon farnesyl group (via farnesyltransferase, FTase) in or a 20-carbon geranylgeranyl group (via geranylgeranyltransferase, GGTase I or II) in Rho and families, enhancing hydrophobicity for plasma membrane or association. Mutations disrupting this C-terminal , as seen in some oncogenic variants of , impair membrane targeting and disrupt normal signaling.80607-8.pdf) Family-specific inserts further diversify the regulatory architecture of small GTPases, inserting unique loops or domains that modulate effector specificity without altering the core GTP-binding mechanism. In the Rho family, an insert loop (approximately residues 122–137 in RhoA) forms a short α-helix that protrudes from the G domain surface, providing a docking platform for Rho-selective partners and distinguishing Rho signaling from that of or . Conversely, Arf family members possess an N-terminal helical domain (about 50–60 residues) that occludes the myristoylation site in the inactive GDP-bound form but relocates upon activation to expose the N-terminal amphipathic helix for membrane insertion, thereby regulating Arf's role in vesicle trafficking. These inserts, absent in , underscore the evolutionary adaptation of small GTPases for specialized cellular contexts. Post-translational modifications of these regulatory regions are essential for proper localization and activity, with prenylation being the most conserved. Following prenylation of the CAAX cysteine, the AAX tripeptide is cleaved by endoproteases like Rce1, and the exposed carboxyl group is methylated by Icmt, increasing hydrophobicity and membrane affinity.80607-8.pdf) Additional modifications include palmitoylation of upstream cysteines in H- and N-Ras (but not K-Ras4B), which forms reversible thioester linkages to further stabilize plasma membrane attachment, and myristoylation of an N-terminal glycine in some Arf and Gα subunits for initial membrane recruitment. In Rho GTPases, geranylgeranylation predominates, often combined with polybasic regions for dual lipid and electrostatic membrane binding, ensuring compartment-specific functions. Disruptions in these modifications, such as through FTase inhibitors, have been explored therapeutically to block oncogenic Ras signaling by preventing membrane localization.

Biochemical Mechanism

GTP/GDP Cycle

Small GTPases function as molecular switches by cycling between an inactive, GDP-bound conformation and an active, GTP-bound conformation, a process central to their role in cellular signaling and regulation. In the inactive state, the GTPase is bound to (GDP), which maintains a closed conformation that limits interactions with downstream effectors. Activation occurs through guanine nucleotide factors (GEFs), which catalyze the of GDP, allowing the higher intracellular concentration of (GTP) to bind and induce the active state. The GTP-bound form then engages effectors to propagate signals, such as in Ras-mediated pathways. The cycle returns to the inactive state via of GTP to GDP and inorganic phosphate (P_i), which can proceed intrinsically at a slow rate or be markedly accelerated by GTPase-activating proteins (GAPs). Small GTPases exhibit exceptionally high affinity for both , with dissociation constants (K_d) typically around 10^{-11} M for GTP and 10^{-10} M for GDP, ensuring stable binding under physiological conditions. This tight binding results in intrinsically slow rates of exchange and , with GDP and GTP half-lives on the order of hours in the absence of regulators, which would otherwise render the cycle biologically inert. For instance, the intrinsic GDP off-rate for , a prototypical small GTPase, is approximately 2 \times 10^{-5} s^{-1}, highlighting the necessity of GEFs to achieve rapid activation. Similarly, the intrinsic GTP rate is low, around 10^{-4} s^{-1} for , corresponding to a turnover of minutes to hours. The GTP/GDP cycle is underpinned by dynamic conformational changes, particularly in the Switch I (residues 30-40 in ) and Switch II (residues 60-76 in ) regions of the G domain. GTP binding coordinates Mg^{2+} and the γ-phosphate, ordering these switches into extended, solvent-exposed conformations that create high-affinity binding sites for effectors. In the GDP-bound state, the switches adopt disordered or compact structures, occluding key interfaces and preventing effector engagement. This binary conformational toggle ensures precise control over signaling fidelity. The hydrolysis reaction itself is represented as: \text{GTP} + \text{H}_2\text{O} \rightarrow \text{GDP} + \text{P}_\text{i} with the intrinsic rate constant k \approx 10^{-4} \text{ s}^{-1}, emphasizing the reliance on GAPs for efficient deactivation.

Intrinsic and Catalyzed Hydrolysis

Small GTPases possess an intrinsic GTPase activity that hydrolyzes bound GTP to GDP and inorganic phosphate (Pi), thereby switching the protein from its active to inactive conformation. This intrinsic hydrolysis is inherently slow, with rate constants typically on the order of 10^{-5} to 10^{-2} s^{-1} for most family members, ensuring prolonged signaling only when regulated. In the Ras family, the mechanism involves positioning a nucleophilic water molecule by residues Thr35 and Gly60 (using Ras numbering) within the active site, while Gln61 orients the water for inline attack on the γ-phosphate of GTP in a substrate-assisted fashion, where the γ-phosphate itself facilitates proton abstraction from the water. The of intrinsic GTP adopts an associative SN2-like , characterized by a pentacoordinate bipyramidal where the attacking water and leaving Pi group achieve partial bonds simultaneously. (DFT) calculations reveal an activation barrier of approximately 20 kcal/ for this process in , with the Mg^{2+} coordinating the β- and γ-phosphates to stabilize the negative charge buildup and lower the energy barrier relative to solution-phase . Quantum mechanical insights further indicate redistribution in the , emphasizing the role of the P-loop (GXXXXGK[S/T]) in substrate binding and the switch I/II regions in catalysis. GTPase-activating proteins (GAPs) dramatically accelerate by up to 10^5-fold in through insertion of an "arginine finger" (e.g., Arg789 in neurofibromin) into the , which neutralizes developing negative charge on the γ-phosphate during the and stabilizes the pentacoordinate intermediate. This also repositions Gln61 to better align the nucleophilic , enhancing general base-like activity without directly deprotonating it. In the Ras-GAP complex, the mechanism proceeds via a similar SN2 pathway but with a reduced activation barrier due to electrostatic stabilization, as confirmed by structural and computational studies. Variations in hydrolysis mechanisms occur across GTPase families, reflecting adaptations to specific cellular roles. In the Rho family, intrinsic rates are comparably slow to , but Rho-specific GAPs employ an arginine finger alongside a residue (e.g., Tyr in p50RhoGAP) that further orients the catalytic (Gln63 in RhoA), achieving rate enhancements of 10^4- to 10^5-fold. Rab family members exhibit even slower intrinsic (rates varying over 20-fold, often <10^{-4} s^{-1}), attributed to a more remote positioning of the catalytic (Gln70 in Rab1), which relies heavily on GAPs for ; RabGAPs use a distinct finger from the GAP itself to position the nucleophilic water, bypassing the need for an arginine finger in some cases. These family-specific differences ensure precise spatiotemporal control of cycling.

Classification

Ras Family

The Ras family constitutes a major branch of the small GTPase superfamily, comprising 36 members organized into seven subfamilies, including the classical (H-Ras, K-Ras, N-Ras), Ral, , Rheb, Rit, Rras, , and DIRAS subfamilies. These proteins are pivotal in regulating and survival through mitogenic signaling pathways. Unlike broader superfamily members, Ras family GTPases primarily localize to the plasma membrane, where they cycle between inactive GDP-bound and active GTP-bound states to transduce extracellular signals. The core G domain of Ras family proteins exhibits high sequence conservation, with over 80% identity among the classical H-Ras, K-Ras, and N-Ras isoforms, enabling shared biochemical mechanisms such as GTP binding and hydrolysis. This domain interacts with specific effectors, notably Raf kinases, which initiate the MAPK/ERK cascade, and class I PI3K isoforms, which activate Akt signaling for cell growth and metabolism; these interactions occur with affinities in the range of 50-200 nM for Raf. Sequence divergence in the C-terminal hypervariable region among family members allows for isoform-specific localization and regulation, distinguishing them from other GTPase branches. A hallmark of Ras family function is their targeting to the inner leaflet of the plasma membrane via post-translational farnesylation of a conserved C-terminal , which facilitates rapid signal propagation in response to growth factors like EGF. This localization supports a fast GTP/GDP cycle, with activation occurring on the order of minutes upon stimulation, enabling transient mitogenic responses essential for progression. Unlike Rho or family , Ras proteins lack regulation by guanine nucleotide dissociation inhibitors (GDIs), relying instead on guanine nucleotide exchange factors (GEFs) for activation and GTPase-activating proteins (GAPs) for deactivation. The Ras family's oncogenic potential is pronounced, stemming from mutations that lock the protein in its GTP-bound state; notably, substitutions at 61 (e.g., Q61L or Q61K) impair intrinsic GTP and GAP-mediated , leading to constitutive effector engagement and uncontrolled in up to 30% of human cancers. These mutations are particularly prevalent in K-Ras, underscoring its role in pancreatic, lung, and colorectal malignancies, and highlight the family's sensitivity to perturbations in the GTP/GDP cycle.

Rho Family

The Rho family of small GTPases comprises approximately 20 canonical members in mammals, classified into subfamilies such as Rho (RhoA, RhoB, RhoC), Rac (Rac1, Rac2, Rac3), Cdc42, and others including RhoD, RhoG, RhoH, RhoU, and RhoV. These proteins are distinguished by their roles in regulating cytoskeletal dynamics and cell morphology through interactions with specific effectors. Unlike other small GTPase families, Rho members feature a unique insert in their core G domain, spanning residues 124–136 in RhoA, which facilitates binding to downstream effectors like p21-activated kinase (PAK) and Rho-associated coiled-coil containing protein kinase (ROCK). Additionally, classical Rho GTPases undergo posttranslational geranylgeranylation at a C-terminal CAAX , enabling their with cellular membranes essential for function. Rho family GTPases exhibit slower nucleotide cycling rates compared to Ras family members, characterized by intrinsically low GDP dissociation and GTP hydrolysis kinetics that maintain them predominantly in the inactive GDP-bound state until stimulated by regulators. This cycling is tightly controlled by guanine nucleotide exchange factors (GEFs) that promote GDP release and GTP loading, and GTPase-activating proteins (GAPs) that accelerate , with Rho proteins interacting with over 85 GEFs and 66 GAPs across the family. Their membrane localization and activity are further modulated through shuttling between the and , mediated by Rho GDP dissociation inhibitors (RhoGDIs). The three mammalian RhoGDIs (RhoGDIα, β, and γ) uniquely regulate Rho family members by binding to the geranylgeranylated and switch I/II regions of the GDP-bound form, thereby masking the anchor and inhibiting spontaneous nucleotide exchange while sequestering the proteins in the to prevent premature effector access. This GDI-mediated extraction from donor membranes forms an inactive cytosolic pool, which can be redirected to target membranes upon , ensuring spatiotemporal control of Rho signaling. In contrast to other families, this shuttling mechanism is particularly pronounced in Rho proteins, contributing to their slower overall cycle.

Rab and Arf Families

The Rab family constitutes the largest subgroup of small GTPases, comprising over 60 members in humans that primarily regulate intracellular vesicle trafficking and identity. These proteins, such as Rab1 involved in ER-to-Golgi and Rab5 in early endosomal dynamics, achieve membrane association through double with geranylgeranyl groups at their C-terminal residues, a process catalyzed by Rab geranylgeranyltransferase (RabGGTase). This lipid modification, combined with a hypervariable C-terminal region, enables -specific localization and interaction with diverse effectors that coordinate vesicle , , and motor recruitment in pathways like endosomal and ER-Golgi trafficking. The Arf family includes 6 core ARF proteins (ARF1–6) and the related subfamily ( and ), which function as molecular switches in membrane remodeling and protein during vesicular transport. Unlike other small , Arfs undergo N-terminal myristoylation and expose an amphipathic α-helix upon GTP binding, facilitating their insertion into bilayers and recruitment of adaptor complexes. For instance, GTP-bound Arf1 recruits coatomer proteins to form COPI vesicles at the Golgi, while Sar1 initiates COPII for anterograde ER-to-Golgi trafficking, thereby specifying selection and vesicle . Rab and Arf families share several biochemical traits that distinguish them from Ras and Rho subfamilies, including intrinsically slow GTP hydrolysis rates that prolong their active states for sustained effector engagement, and membrane-anchored guanine nucleotide exchange factors (GEFs) that promote localized activation. Their organelle-specific localization—driven by 's C-terminal prenyl anchors and Arf's N-terminal helical insertion—underpins roles in defining compartment identity during vesicle dynamics, contrasting with the plasma membrane-centric signaling of and Rho GTPases.

Ran and Other Families

The Ran family consists of a single member in mammals, Ran, a small GTPase essential for maintaining nuclear-cytoplasmic partitioning. Unlike typical small GTPases, Ran lacks a C-terminal and is therefore not subject to , relying instead on the asymmetric distribution of its regulators for subcellular localization. The (GEF) for Ran, RCC1, is chromatin-bound within the , promoting GDP-to-GTP exchange and generating high levels of RanGTP in this compartment. In contrast, the GTPase-activating protein (GAP) RanGAP operates in the , accelerating GTP hydrolysis to favor the GDP-bound form of Ran outside the . This spatial segregation of RCC1 and RanGAP establishes a steep RanGTP/GDP gradient across the complex, driving directional of proteins bearing nuclear localization signals (NLS) into the and export signals () out of it. The Miro family represents an atypical branch of small GTPases localized to the outer mitochondrial membrane, with two principal members, Miro1 and Miro2, playing critical roles in organelle dynamics. These proteins feature two GTP-binding domains flanking a central region with two calcium-binding EF-hand motifs, enabling calcium-sensitive regulation of their activity. In response to elevated cytosolic calcium, the EF-hands bind Ca²⁺, which modulates Miro's interaction with motor proteins such as kinesin-1 and , thereby controlling the bidirectional microtubule-based transport of mitochondria along neuronal axons and in other types. This calcium-dependent mechanism allows Miro to sense local environmental changes, halting mitochondrial movement near sites of high calcium influx, such as active synapses, to facilitate processes like energy supply and calcium buffering. Other families of GTP-binding proteins exhibit deviations from classical small GTPase paradigms, expanding the functional diversity within this superfamily. Septins, for instance, form a family of filament-forming GTP-binding proteins involved in cytokinesis and membrane remodeling, but they display atypical GTP hydrolysis with weak or negligible activity in many members, functioning more as structural GTP binders that stabilize complexes rather than cycling between active and inactive states like canonical GTPases. Emerging families, such as the RGK subfamily including GEM (also known as Kir/Gem), Rem, and Rad, are Ras-related GTPases that regulate voltage-gated calcium channels and cytoskeletal dynamics through unique effector interactions, often independent of traditional GEF/GAP regulation. These atypical features highlight how GTP-binding motifs can support specialized roles beyond standard signal transduction.

Cellular Functions

Signal Transduction Pathways

Small GTPases, particularly those in the Ras family, serve as critical molecular switches in pathways that relay extracellular cues to intracellular responses, primarily regulating , , and survival. In the canonical Ras pathway, receptor tyrosine kinases (RTKs) such as the (EGFR) are activated by ligands like (EGF), leading to autophosphorylation and recruitment of the adaptor protein , which in turn binds the (GEF) Sos. Sos catalyzes the exchange of GDP for GTP on , converting it to its active Ras-GTP form that docks at the plasma membrane. Active Ras-GTP then recruits and activates downstream effectors, most prominently the Raf kinases (ARAF, BRAF, CRAF), initiating the (MAPK) cascade. Raf phosphorylates and activates MEK1/2, which in turn dually phosphorylates ERK1/2; activated ERK translocates to the nucleus to phosphorylate transcription factors such as Elk-1 and c-Fos, ultimately driving expression of genes like c-Myc and that promote progression and . This pathway exemplifies how Ras integrates signals to orchestrate transcriptional programs essential for cellular . Rho family GTPases contribute to signal transduction through crosstalk with Ras pathways, particularly in response to integrin-mediated adhesion signals that influence cell motility and stress responses. Upon extracellular matrix engagement, integrins activate Rho GTPases like RhoA via GEFs such as p115RhoGEF, shifting Rho to its GTP-bound state. Active Rho-GTP binds effectors including Rho-associated coiled-coil kinase (ROCK) and p21-activated kinase (PAK), which phosphorylate targets to modulate the actin cytoskeleton and activate parallel MAPK branches. Specifically, ROCK inhibits myosin phosphatase to enhance actomyosin contractility, while PAK activates the JNK MAPK pathway by phosphorylating MAP kinase kinases, leading to activation and changes that support and survival. This Rho-mediated signaling intersects with -ERK by shared upstream RTK inputs and downstream convergence on JNK, allowing coordinated regulation of proliferative and migratory responses without direct overlap in core Ras cascades. The diversity of Ras effectors enables multifaceted signal propagation, with over 20 identified downstream targets that amplify and diversify outputs from Ras-GTP. For instance, RalGDS (Ral guanine nucleotide dissociation stimulator) is recruited by Ras-GTP to activate the Ral GTPase pathway, influencing vesicle trafficking and independent of the Raf-MEK-ERK axis. Negative regulation is maintained through feedback loops involving RasGAPs (GTPase-activating proteins), such as neurofibromin (NF1), which accelerate GTP hydrolysis on Ras to revert it to the inactive GDP-bound state, thereby terminating signaling and preventing sustained activation. ERK itself contributes to this feedback by phosphorylating Sos, reducing its GEF activity and thus limiting further Ras activation. Spatial organization on the plasma enhances the efficiency of these pathways, with proteins assembling into transient —discrete platforms approximately 10-20 nm in diameter containing 5-10 Ras molecules—that facilitate high-fidelity effector recruitment. These segregate GTP- and GDP-bound into non-overlapping domains, driven by lipid interactions (e.g., and PIP2 enrichment), ensuring that active Ras-GTP colocalizes with effectors like Raf for rapid signal amplification while isolating inactive forms to minimize noise. This nanoscale compartmentalization, observed across Ras isoforms (H-Ras, K-Ras, N-Ras), underscores how converts GTP binding into precise, directional signaling outputs.

Membrane Trafficking and Transport

Small GTPases of the Rab family play a central role in coordinating trafficking by regulating the formation, movement, and of transport vesicles across various cellular compartments. Specifically, proteins act as molecular switches, cycling between GTP-bound active states that recruit effectors to promote vesicle and , and GDP-bound inactive states that allow . In the endocytic pathway, Rab5 localizes to early endosomes and facilitates their maturation and homotypic by recruiting the effector early endosomal autoantigen 1 (EEA1), which tethers vesicles through interactions with SNARE proteins and phosphatidylinositol 3-phosphate (PI3P). This EEA1-mediated ensures precise docking before , enabling efficient sorting of internalized cargo such as receptors. Further along the endocytic route, Rab11 associates with recycling endosomes, where it directs the return of selected cargo, like transferrin receptors, to the plasma membrane via interactions with effectors such as Rab11-FIP2 that link to motor proteins and cytoskeletal elements. In late-stage trafficking, particularly for retrograde transport from late endosomes to the trans-Golgi network (TGN), Rab9 recruits the Golgi-associated retrograde protein (GARP) complex, which tethers vesicles and promotes SNARE assembly for fusion, thereby maintaining compartment-specific delivery of mannose-6-phosphate receptors. The Arf family contributes to anterograde and intra-Golgi trafficking by initiating coat assembly on vesicles. Arf1, activated at the Golgi, recruits the coat protein complex I (COPI) coatomer to form vesicles that mediate retrograde within the Golgi stack and from the Golgi to the (), with Arf1-GTP binding directly to coatomer subunits to stabilize the coat lattice.90218-S) Similarly, Sar1, an Arf-like GTPase, drives COPII coat formation at ER exit sites, where its GTP-bound form inserts into the to recruit Sec23/24 and Sec13/31, generating vesicles for anterograde ER-to-Golgi and ensuring selective of secretory cargo.90150-7) Ran GTPase governs nuclear transport by establishing a GTP/GDP gradient across the , maintained by chromatin-bound RCC1 () in the and cytoplasmic RanGAP1, which powers directionality through karyopherin family members (importins and exportins). Importins bind cargo in the (low Ran-GTP), translocate through nuclear pores, and release cargo upon Ran-GTP binding in the ; conversely, exportins like CRM1 bind nuclear export signals and Ran-GTP to export cargo unidirectionally to the , where GTP dissociates the complex. These GTPases achieve compartment fidelity through coordinated cascades and post-translational modifications. For instance, in , Rab4 on sorting endosomes promotes rapid , while sequential activation converts Rab4 domains to Rab5-positive early endosomes via shared effectors and GEFs, ensuring progressive maturation without mixing of cargo fates. with geranylgeranyl groups at the C-terminal residues anchors Rabs and Arfs to specific bilayers, preventing off-target localization and enabling precise effector recruitment for pathway fidelity.

Cytoskeletal Organization

Small GTPases of the Rho family are pivotal regulators of cytoskeletal organization, particularly through their control of dynamics and integration with networks to drive and . RhoA, in its GTP-bound form, interacts with downstream effectors such as the formin mDia1 and the kinase to nucleate linear filaments and promote myosin II-mediated contractility, respectively, leading to the assembly of thick that anchor focal adhesions and maintain cellular tension. These interactions enable cells to generate contractile forces essential for adhesion maturation and rearward retraction during movement.00107-5) In contrast, Rac1 activates the WAVE regulatory complex, which recruits and stimulates the Arp2/3 complex to initiate branched actin polymerization at the plasma membrane, forming sheet-like lamellipodia that facilitate leading-edge protrusion in motile cells. Cdc42, another Rho family member, engages neural WASP (N-WASP) to similarly activate Arp2/3 but favors unbranched, bundled actin structures via cofilin-mediated severing and formin elongation, resulting in thin, finger-like filopodia that sense environmental cues and guide directional migration. These effector-specific pathways allow precise spatial control of actin architecture, with RhoA dominating at the cell rear for contraction, Rac1 at the front for extension, and Cdc42 at protrusive tips for exploration. Beyond actin, Rho GTPases influence microtubule stability and function, linking the two cytoskeletal systems for coordinated . RhoA promotes microtubule stabilization by modulating stathmin activity through downstream kinases, preventing and supporting capture at the cortex to reinforce . Miro GTPases, a distinct subfamily, facilitate kinesin-mediated anterograde transport of mitochondria along by binding /TRAK adaptor proteins, ensuring energy supply to motile regions like growth cones. Cdc42 further contributes to establishment, as exemplified in asymmetric division where its activation directs cortical patches to the bud site, initiating polarized growth.00547-8) Dynamic gradients of Rho GTPase activity fine-tune cytoskeletal remodeling during , with localized inactivation ensuring efficient turnover. For instance, Rac1 activity peaks at the to drive protrusion but is suppressed at the trailing edge via reciprocal antagonism with RhoA, promoting contractility and detachment to propel forward movement. These spatio-temporal patterns, often visualized through FRET-based sensors, highlight how GTPase cycles create self-organizing waves that sustain persistent without global activation.

Pathophysiological Roles

Oncogenic Mutations and Cancer

Mutations in small GTPases, particularly those in the Ras family, play a pivotal role in oncogenesis by locking the proteins in a constitutively active GTP-bound state, thereby promoting tumorigenesis. Activating mutations in genes (, , ) occur in approximately 19% of all human cancers, with hotspots primarily at codons 12 (e.g., G12D, G12V), 13 (G13D), and 61 (Q61L or Q61R), which impair GTPase-activating protein ()-stimulated hydrolysis and prevent GTP-to-GDP conversion. These mutations are particularly prevalent in specific malignancies, such as mutations found in over 90% of pancreatic ductal adenocarcinomas, driving aggressive tumor growth. The oncogenic effects of mutant Ras stem from persistent downstream signaling through pathways like Raf/MEK/ERK and PI3K/Akt, leading to uncontrolled , enhanced survival via upregulation of anti-apoptotic proteins such as , and promotion of through increased VEGF expression. This hyperactivation disrupts normal , fostering including evasion of and sustained proliferative signaling. Beyond , dysregulation in other small GTPase families contributes to cancer progression. Overexpression of RhoC, a Rho family member, enhances tumor cell motility and invasion, facilitating in cancers such as and pancreatic . Similarly, elevated Rab25 expression promotes epithelial-mesenchymal and invasiveness in colorectal and ovarian cancers by altering endocytic recycling and trafficking. Therapeutic strategies targeting oncogenic small GTPases have evolved, with early efforts focusing on farnesyltransferase inhibitors like tipifarnib to block Ras membrane localization; however, these showed limited clinical success due to alternative pathways compensating for farnesylation inhibition. More recent advances include covalent inhibitors specific to G12C, such as , which received FDA accelerated approval in 2021 for treating G12C-mutated non-small cell by irreversibly binding the mutant residue in the inactive GDP-bound state. In May 2025, the FDA granted accelerated approval to the combination of avutometinib and defactinib for -mutated recurrent low-grade serous , marking further progress in targeting Ras pathway dysregulation.

Dysregulation in Non-Cancerous Diseases

Small GTPases play critical roles in non-cancerous diseases through dysregulation of their signaling and trafficking functions. In neurodegenerative disorders, mutations in kinase 2 () lead to hyperactive activity that phosphorylates Rab1, impairing its role in endoplasmic reticulum-to-Golgi transport and contributing to lysosomal dysfunction in . This phosphorylation disrupts Rab1 hydrolysis and effector interactions, exacerbating and neuronal loss observed in affected patients. Similarly, hyperactivity of RhoA, often mediated by its downstream effector , promotes tau hyperphosphorylation via GSK3β activation, driving formation and synaptic dysfunction in Alzheimer's disease . Pathogenic bacteria exploit small GTPases to facilitate host cell invasion and intracellular survival. During Salmonella enterica infection, the type III secretion system effector SopE acts as a guanine nucleotide exchange factor (GEF) that activates Rac1 and, to a lesser extent, RhoA in vitro, inducing actin rearrangements and membrane ruffling essential for bacterial entry into non-phagocytic cells. In Legionella pneumophila infection, the effector SidM (also known as DrrA) functions as a GEF for Rab1, promoting its recruitment to the Legionella-containing vacuole and enabling ER-derived membrane acquisition for pathogen replication. These manipulations highlight how microbial GEFs mimic host regulators to subvert vesicular trafficking. Dysregulation of small GTPases also underlies developmental disorders. In , a characterized by congenital anomalies including cardiac defects, germline mutations in (encoding SHP2) enhance Ras signaling by impairing negative regulation akin to RasGAP function, leading to hyperactivation of downstream MAPK pathways during embryogenesis. Similarly, missense mutations in Rab7, such as L191R and N161T, cause Charcot-Marie-Tooth type 2B neuropathy by altering late endosomal trafficking, resulting in impaired neurotrophic factor receptor degradation and axonal degeneration. In cardiovascular diseases, small contribute to pathological vascular remodeling. Arf1, through its regulation of COPI-coated vesicle formation and dynamics in macrophages, facilitates cholesterol ester accumulation and formation, promoting atherosclerotic plaque progression. Dysfunctions in the Ran pathway, particularly involving Ran-binding proteins like RANBP1, are implicated in congenital heart defects such as those in , where altered nuclear transport disrupts cardiogenic and septal development.

References

  1. [1]
    Targeting small GTPases: emerging grasps on previously ... - Nature
    In this article, we summarize diversified biological functions, shared structural properties, and complex regulatory mechanisms of small GTPases ...
  2. [2]
    Small GTPases: Structure, biological function and its interaction with ...
    Small GTPase is a kind of GTP-binding protein commonly found in eukaryotic cells. It plays an important role in cytoskeletal reorganization, cell polarity, ...
  3. [3]
    Small GTPases Take the Stage - ScienceDirect
    Small GTPases are molecular switches that have been adopted to control many eukaryotic cell functions. Starting with the study of the protooncogene Ras in ...
  4. [4]
    EC 3.6.5.2 - small monomeric GTPase.
    1.46. Involved in cell-growth regulation (Ras subfamily), membrane vesicle traffic and uncoating (Rab and Arf subfamilies), nuclear protein import (Ran ...Missing: definition | Show results with:definition
  5. [5]
    3.6.5.2 Small monomeric GTPases in GtoPdb v.2025.3
    Sep 10, 2025 · 3.6.5.2 Small monomeric GTPases ... Small G-proteins, are a family of hydrolase enzymes that can bind and hydrolyze guanosine triphosphate (GTP).Missing: definition EC
  6. [6]
    The Ras superfamily at a glance | Journal of Cell Science
    Mar 1, 2005 · The Ras superfamily of small guanosine triphosphatases (GTPases) comprise over 150 human members (Table S1 in supplementary material), with evolutionarily ...
  7. [7]
    The GTPase superfamily: a conserved switch for diverse cell functions
    Nov 8, 1990 · GTPases are proteins that bind and hydrolyse GTP, acting as molecular switches with 'on' and 'off' states triggered by GTP binding and ...
  8. [8]
    Structural Insights into the Regulation Mechanism of Small GTPases ...
    Small GTPases are typically 20–30 kDa in size and can work as molecular ... Structural evidence for a common intermediate in small G protein-GEF reactions.
  9. [9]
    Regulation of Small GTPases by GEFs, GAPs, and GDIs
    The story of small GTPases started more than three decades ago with the discovery of the Ras oncogene, which was soon followed by a flurry of discoveries of ...
  10. [10]
    Evolution and Diversity of the Ras Superfamily of Small GTPases in ...
    Dec 4, 2014 · It has been found that genes encoding small GTPases and MglB homologs are often coupled in prokaryotic genomes (i.e., encoded near each other ...
  11. [11]
    The pseudoGTPase group of pseudoenzymes - Stiegler - FEBS Press
    Sep 7, 2020 · Small GTPases are important signaling molecules that function widely as regulators of signal transduction and cellular function. The 150+ ...
  12. [12]
    Small GTPases: Structure, biological function and its interaction with ...
    Jul 31, 2018 · Classification of small GTPase protein​​ At present, the family has over 150 members making it a superfamily.
  13. [13]
    The structural basis for the transition from Ras-GTP to Ras-GDP - NIH
    Comparison of the GTP- and GDP-bound structures of Ras has identified two regions referred to as switch 1 (residues 30–40) and switch 2 (residues 60–76), ...
  14. [14]
    All ras proteins are polyisoprenylated but only some are palmitoylated
    The C-terminal CAAX motif of the yeast mating factors is modified by proteolysis to remove the three terminal amino acids (-AAX) leaving a C-terminal ...
  15. [15]
    The RHO Family GTPases: Mechanisms of Regulation and Signaling
    Jul 20, 2021 · ARF GAP and scaffold, Regulation of cell adhesion and differentiation ... A characteristic region of RHO family GTPases is the insert helix ...
  16. [16]
    ADP-Ribosylation Factor Family of Small GTP-Binding Proteins
    Here we review recent progress in understanding the membrane recruitment, activation, crosstalk, and functions of ARF family proteins.
  17. [17]
    Small GTPases and their GAPs - PMC - NIH
    Here we review developments leading to current understanding of intrinsic and GAP catalyzed GTP hydrolytic reactions in small GTPases from structural, molecular ...Missing: paper | Show results with:paper
  18. [18]
    GTP Hydrolysis Without an Active Site Base: A Unifying Mechanism ...
    Jun 14, 2019 · Our results demonstrate that a general base is not needed in the active site, as the preferred mechanism for GTP hydrolysis is a conserved solvent-assisted ...
  19. [19]
    Ras-Specific GTPase-Activating Proteins—Structures, Mechanisms ...
    Additional residues and motifs in GAP stabilize the switch I and switch II regions of Ras/Rap, supporting a conformation that is favorable for efficient GTP ...
  20. [20]
    Assessing the Influence of Mutation on GTPase Transition States by ...
    May 12, 2017 · DFT calculations identify electron-density redistribution and pinpoint why the TS for guanosine 5′-triphosphate (GTP) hydrolysis is higher ...
  21. [21]
    Recent Advances in Understanding Biological GTP Hydrolysis ...
    Feb 28, 2020 · In this mini-review, we discuss advances in our understanding of biological GTP hydrolysis based on recent computational studies.
  22. [22]
    The arginine finger of RasGAP helps Gln-61 align the nucleophilic ...
    Guanine nucleotide exchange factors catalyze the dissociation of GDP from Ras and thus promote the loading of GTP to regenerate the active state. The accessory ...
  23. [23]
    Catalytic mechanism of a mammalian Rab·RabGAP complex in ...
    Dec 12, 2012 · Rab GTPases, key regulators of vesicular transport, hydrolyze GTP very slowly unless assisted by Rab GTPase-activating proteins (RabGAPs).Results · Kinetics Of Gtp Hydrolysis · Mechanism Of Gtp Hydrolysis<|separator|>
  24. [24]
    Structural plasticity mediates distinct GAP‐dependent GTP ...
    Nov 2, 2017 · Generally, Rabs have a low intrinsic GTP hydrolysis rate, although the rate constants vary by more than 20-fold among various Rab members [27].<|separator|>
  25. [25]
  26. [26]
    A potent KRAS macromolecule degrader specifically targeting ...
    Jun 26, 2020 · ... sequence identity between the three RAS isoforms (more than 80%). However, our recently described KRAS-specific DARPins showed the ...
  27. [27]
  28. [28]
    Temporally-regulated quick activation and inactivation of Ras is ...
    Jul 9, 2012 · In most cases, Ras is activated in the order of minutes by a guanine nucleotide exchange factor (GEF) and then activates the MAPK pathway to ...
  29. [29]
  30. [30]
    Small GTPases of the Rab and Arf Families: Key Regulators of ...
    The Rab GTPases, the largest family of the Ras superfamily, are key regulators of vesicle sorting and membrane trafficking. They can control this traffic by ...
  31. [31]
    The Regulatory RAB and ARF GTPases for Vesicular Trafficking - NIH
    The RAB and ARF GTPases are members of two of the RAS-related subfamilies that function in regulating vesicle trafficking.
  32. [32]
    Rab family of small GTPases: an updated view on their regulation ...
    The Rab family of small GTPases regulates intracellular membrane trafficking by orchestrating the biogenesis, transport, tethering, and fusion of membrane‐bound ...
  33. [33]
    ARF family G proteins and their regulators: roles in membrane ...
    May 18, 2011 · ARFs have several important functions, including the recruitment of coat proteins that promote sorting of cargo into vesicles, the recruitment ...
  34. [34]
  35. [35]
    Ran GTPase: A Key Player in Tumor Progression and Metastasis
    Ran is unique among other GTPases owing to its acidic tail at the C-terminus. Furthermore, unlike the other GTPases, Ran lacks the CAAX motif, a membrane ...Missing: prenylation | Show results with:prenylation
  36. [36]
    Structural basis for a nucleoporin exportin complex between ...
    Jul 11, 2025 · The Ran gradient is maintained by the cytoplasmic Ran GTPase activating protein RanGAP1 that stimulates GTP hydrolysis to convert Ran(GTP) to ...Missing: prenylation | Show results with:prenylation
  37. [37]
    MIRO GTPases in Mitochondrial Transport, Homeostasis and ...
    Dec 31, 2015 · It has two GTPase domains instead of the one found in other small GTPases, and it also has two EF hand calcium binding domains, which allow Ca2+ ...
  38. [38]
    The Miro GTPases: At the heart of the mitochondrial transport ...
    May 6, 2009 · The Miro proteins harbour two GTPase domains that flank a pair of calcium-binding EF-hands. The EF hands are functional, since they were shown ...
  39. [39]
    Understanding Miro GTPases: Implications in the Treatment of ...
    Feb 6, 2018 · Interestingly, the Miro EF-hands are not only involved in binding calcium [56], but in sensing the influx of Ca2+ during synaptic activation, ...
  40. [40]
    Septins: Active GTPases or just GTP-binding proteins? - PubMed
    While most septins bind GTP, display weak GTP-hydrolysis activity and incorporate guanine nucleotides in their interaction interfaces, studies using GTPase ...Missing: atypical | Show results with:atypical
  41. [41]
    Gem: an Induced, Immediate Early Protein Belonging to the Ras ...
    Gem and Rad, the product of a gene overexpressed in skeletal muscle in individuals with Type II diabetes, constitute a new family of Ras-related GTP-binding ...
  42. [42]
    Targeting the RAS/RAF/MAPK pathway for cancer therapy - Nature
    Dec 18, 2023 · In this review, we delve deeper into the mechanistic insights surrounding RAF kinase signaling in tumorigenesis and RAFi-resistance.
  43. [43]
    RAS Proteins and Their Regulators in Human Disease - PMC
    RAS proteins are binary switches, cycling between ON and OFF states during signal transduction. These switches are normally tightly controlled.Ras Effectors · Ras Proteins In The Membrane · Ras And Human Disease
  44. [44]
    Rho GTPases and signaling networks - Genes & Development
    Overexpression of Tiam in fibroblasts elicited the formation of membrane ruffles and activation of JNK in a Rac-dependent manner (Michiels et al. 1995, 1997).
  45. [45]
    letters Structural basis for the interaction of Ras with RalGDS - Nature
    The Ras protein signals to a number of distinct pathways by interacting with diverse downstream effectors. Among the effectors of Ras are the Raf kinase and ...
  46. [46]
    Feedback activation of neurofibromin terminates growth factor ...
    Feb 9, 2016 · Our findings show that, in addition to feedback inhibition of Sos, feedback stimulation of the RasGAP neurofibromin enforces termination of the Ras signal.
  47. [47]
    Ras and the Plasma Membrane: A Complicated Relationship - NIH
    In this review, we will discuss the spatiotemporal organization of Ras proteins on the cell plasma membrane (PM) and the emergent signaling consequences.
  48. [48]
    Ras nanoclusters: Versatile lipid-based signaling platforms
    Ras proteins assemble into transient nanoclusters on the plasma membrane. Nanoclusters are the sites of Ras effector recruitment and activation.
  49. [49]
    Rho GTPases and the Actin Cytoskeleton - Science
    Members of the Rho GTPase family are key regulatory molecules that link surface receptors to the organization of the actin cytoskeleton.Missing: Alan | Show results with:Alan
  50. [50]
    p140mDia, a mammalian homolog of Drosophila diaphanous,is a ...
    We have identified a protein, p140mDia, as a downstream effector of Rho. It is a mammalian homolog of Drosophila diaphanous, a protein required for cytokinesis.
  51. [51]
    Cooperation between mDia1 and ROCK in Rho-induced actin ...
    Active mDia1 induces the formation of thin actin stress fibres, which are disorganized in the absence of activity of the Rho-associated kinase ROCK.Missing: mDia 1997
  52. [52]
    CDC42 and CDC43, two additional genes involved in budding and ...
    Jul 1, 1990 · CDC42 and CDC43, two additional genes involved in budding and the establishment of cell polarity in the yeast Saccharomyces cerevisiae.
  53. [53]
    Spatio-temporal Rho GTPase signaling – where are we now?
    Jun 1, 2010 · Rho GTPases are key regulators of cytoskeletal dynamics in a wide variety of morphogenetic events, such as cell migration, axonal guidance, ...
  54. [54]
    The Frequency of Ras Mutations in Cancer - PubMed - NIH
    The Frequency of Ras Mutations in Cancer. Cancer Res. 2020 Jul 15;80(14):2969- ... Humans; Incidence; Mutation Rate*; Mutation*; Neoplasms / epidemiology* ...
  55. [55]
    RhoC: a fascinating journey from a cytoskeletal organizer to a ...
    Jul 24, 2019 · It has been shown to impact the motility of cancer cells, resultantly affecting invasion and metastasis, and has contributed to carcinoma ...
  56. [56]
    Rab25 GTPase: Functional roles in cancer - Oncotarget
    Sep 8, 2017 · Rab25 was reported to initiate cancer formation, promote cell proliferation, suppress apoptotic cell death, enhance cell migration/invasion and ...
  57. [57]
    FDA Approval Summary: Sotorasib for KRAS G12C Mutated ...
    On May 28, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to sotorasib (Lumakras™, Amgen) for the treatment of adults with ...
  58. [58]
    An Update on the Interplay between LRRK2, Rab GTPases and ...
    Nov 13, 2023 · Rab1 is the newest Rab GTPase found to be a substrate of LRRK2 [69]. The classical role of Rab1 is its involvement in ER-Golgi transport and ...
  59. [59]
    RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding ...
    Role of Rhoa/Rock Signaling ... Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.
  60. [60]
    Structural basis for the reversible activation of a Rho protein by ... - NIH
    One of these translocated Salmonella toxins, SopE, can activate Cdc42 in a Dbl-like fashion despite its lack of sequence similarity to Dbl-like proteins, the ...
  61. [61]
    Rab1-AMPylation by Legionella DrrA is allosterically activated by ...
    Jan 19, 2021 · Rab1 controls vesicular transport from the endoplasmic reticulum (ER) to the Golgi apparatus. However, it is subjected to intense manipulation ...
  62. [62]
    Mouse model of Noonan syndrome reveals cell type - PubMed - NIH
    Mutations of Ptpn11 (also known as Shp2), which encodes the protein-tyrosine phosphatase Shp2, occur in approximately 50% of individuals with Noonan syndrome ...
  63. [63]
    Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Cause ...
    Background: Four Rab7 GTPase missense mutants cause autosomal dominant peripheral neuropathy Charcot-Marie-Tooth type 2B (CMT2B) disease.
  64. [64]
    Arf1/COPI machinery acts directly on lipid droplets and enables their ...
    Feb 4, 2014 · The Arf1/COPI protein machinery, known for its role in vesicle trafficking, regulates LD morphology, targeting of specific proteins to LDs and lipolysis ...
  65. [65]
    RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in ...
    Jan 12, 2023 · Characteristic symptoms include heart defects, facial abnormalities, cleft palate, hypocalcemia (often auto-regressive), liver abnormalities ...